Paraneoplastic Syndromes Related to Lung Cancer
- 1 June 2010
- journal article
- review article
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 14 (3) , 357-64
Abstract
Paraneoplastic syndromes (PNSs) are defined as signs or symptoms that occur as a result of organ or tissue damage at locations that are remote from the primary tumor site or metastases. Many cancers are associated with PNSs; however, small cell lung cancer (SCLC) is the most prevalent. In SCLC, the systems primarily affected by PNSs include the endocrine system, the neurologic system, and the integumental system. This article provides an overview of primary disorders and classical syndromes, as well as symptom management associated with each system. PNSs are rare, and the best approach is to treat the underlying tumor. Therefore, oncology nurses and other healthcare practitioners should be familiar with PNSs so that they can take prompt and proper courses of action, potentially leading to positive outcomes for patients.Keywords
This publication has 15 references indexed in Scilit:
- Tumor-Related HyponatremiaClinical Medicine & Research, 2007
- Paraneoplastic disorders of the nervous systemEuropean Journal of Cancer Supplements, 2007
- Paraneoplastic neurological syndromesOrphanet Journal of Rare Diseases, 2007
- DermatomyositisClinics in Dermatology, 2006
- Management of paraneoplastic neurological syndromes: report of an EFNS Task ForceEuropean Journal of Neurology, 2006
- Paraneoplastic Syndromes Affecting the Nervous SystemSeminars in Oncology, 2006
- Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromesActa Neurologica Scandinavica, 2006
- Managing Paraneoplastic Neurological DisordersThe Oncologist, 2006
- Hypercalcemia Associated with CancerNew England Journal of Medicine, 2005
- Hypercalcemia of malignancySeminars in Nephrology, 2004